The incretin glucagon-like peptide-1 (GLP-1) is a rhythmically secreted insulin-secretion enhancing hormone produced in the intestinal L-cell. The increasing incidence of Type 2 Diabetes warrants the advent of new therapies that can increase endogenous GLP-1 secretion, which will manipulate regulatory L-cell secretory pathways such as exocytosis. Three exocytotic proteins have already been identified as regulators of GLP-1 secretion. I hypothesized that the accessory exocytotic protein, Munc18-1, is also an important regulator of GLP-1 secretion in the L-cell - specifically at the peak of its secretion. Munc18-1 expression in many, but not all L-cells was confirmed, and its recruitment to the cell membrane was observed under stimulation. Th...
Glucagon-like peptide-1 (GLP-1) is an incretin hormone secreted from entero-endocrine L cells in res...
grantor: University of TorontoIncretins are hormones that are released from the gut in res...
The glucagon-like peptide 1 (GLP-1) receptor (GLP-1R) is a key target for type 2 diabetes (T2D) trea...
Glucagon-like peptide-1 (GLP-1) is an intestinal L-cell hormone that potentiates glucose- dependent ...
Glucagon-like peptide-1 (GLP-1) is an intestinal L-cell hormone that potentiates glucose- dependent ...
Glucagon-like peptide-1 (GLP-1) is a potent incretin hormone currently under investigation for use a...
Glucagon-like peptide-1 (GLP-1) is a potent incretin hormone currently under investigation for use a...
Abstract Background and aim: Diabetes mellitus (DM) is a chronic and progressive illness that affect...
Glucagon-like peptide-1 (GLP-1) is an incretin hormone produced by the enteroendocrine L-cell that p...
Abstract Background and aim: Diabetes mellitus (DM) is a chronic and progressive illness that affect...
Glucagon-like Peptide-1 (GLP-1) is an incretin secreted from intestinal L-cells. Although pathways p...
Glucagon-like Peptide-1 (GLP-1) is an incretin secreted from intestinal L-cells. Although pathways p...
Exocytosis of the hormone, glucagon-like peptide-1 (GLP-1), by the intestinal L-cell is essential fo...
Glucagon-like peptide-1 (GLP-1) is an incretin hormone secreted from entero-endocrine L cells in res...
There are many contributing factors to the development of type 2 diabetes, however, failure of beta-...
Glucagon-like peptide-1 (GLP-1) is an incretin hormone secreted from entero-endocrine L cells in res...
grantor: University of TorontoIncretins are hormones that are released from the gut in res...
The glucagon-like peptide 1 (GLP-1) receptor (GLP-1R) is a key target for type 2 diabetes (T2D) trea...
Glucagon-like peptide-1 (GLP-1) is an intestinal L-cell hormone that potentiates glucose- dependent ...
Glucagon-like peptide-1 (GLP-1) is an intestinal L-cell hormone that potentiates glucose- dependent ...
Glucagon-like peptide-1 (GLP-1) is a potent incretin hormone currently under investigation for use a...
Glucagon-like peptide-1 (GLP-1) is a potent incretin hormone currently under investigation for use a...
Abstract Background and aim: Diabetes mellitus (DM) is a chronic and progressive illness that affect...
Glucagon-like peptide-1 (GLP-1) is an incretin hormone produced by the enteroendocrine L-cell that p...
Abstract Background and aim: Diabetes mellitus (DM) is a chronic and progressive illness that affect...
Glucagon-like Peptide-1 (GLP-1) is an incretin secreted from intestinal L-cells. Although pathways p...
Glucagon-like Peptide-1 (GLP-1) is an incretin secreted from intestinal L-cells. Although pathways p...
Exocytosis of the hormone, glucagon-like peptide-1 (GLP-1), by the intestinal L-cell is essential fo...
Glucagon-like peptide-1 (GLP-1) is an incretin hormone secreted from entero-endocrine L cells in res...
There are many contributing factors to the development of type 2 diabetes, however, failure of beta-...
Glucagon-like peptide-1 (GLP-1) is an incretin hormone secreted from entero-endocrine L cells in res...
grantor: University of TorontoIncretins are hormones that are released from the gut in res...
The glucagon-like peptide 1 (GLP-1) receptor (GLP-1R) is a key target for type 2 diabetes (T2D) trea...